136 related articles for article (PubMed ID: 32162698)
1. Adenovirus infection among pediatric patients with cancer and in pediatric recipients of hematopoietic stem cell: A multicenter nationwide study.
Zając-Spychała O; Pieczonka A; Wachowiak J; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Kazanowska B; Wróbel G; Chybicka A; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Więcek P; Szmydki-Baran A; Hutnik Ł; Matysiak M; Irga-Jaworska N; Bień E; Drożyńska E; Stolpa W; Sobol-Milejska G; Pierlejewski F; Młynarski W; Gryniewicz-Kwiatkowska O; Gietka A; Dembowska-Bagińska B; Semczuk K; Dzierżanowska-Fangrat K; Gamrot-Pyka Z; Woszczyk M; Urbanek-Dądela A; Karolczyk G; Płonowski M; Krawczuk-Rybak M; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Styczyński J
J Med Virol; 2020 Dec; 92(12):3187-3193. PubMed ID: 32162698
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome.
Balletto E; Ponzano M; Raiola AM; Gambella M; Grazia CD; Dominietto A; Giannoni L; Ghiso A; Nicolini LA; Sepulcri C; Ullah N; Bruzzone B; Signori A; Angelucci E; Bassetti M; Mikulska M
Transpl Infect Dis; 2024 Apr; 26(2):e14215. PubMed ID: 38192010
[TBL] [Abstract][Full Text] [Related]
3. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States.
Papanicolaou GA; Dvorak CC; Dadwal S; Maron G; Prasad VK; Giller R; Abdel-Azim H; Sadanand A; Casciano R; Chandak A; Huang S; Nichols G; Brundage T; Vainorius E; Mozaffari E; Hutcheson R
Transpl Infect Dis; 2020 Aug; 22(4):e13283. PubMed ID: 32267590
[TBL] [Abstract][Full Text] [Related]
5. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
Hubmann M; Fritsch S; Zoellner AK; Prevalsek D; Engel N; Bücklein V; Mumm F; Schulz C; Stemmler HJ; Jäger G; Ledderose G; Kolb HJ; Hausmann A; Hiddemann W; Moosmann A; Tischer J
J Clin Virol; 2016 Sep; 82():33-40. PubMed ID: 27428881
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience.
Kasow KA; Krueger J; Srivastava DK; Li C; Barfield R; Leung W; Horwitz EM; Madden R; Woodard P; Hussain I; McCarville MB; Handgretinger R; Hale GA
Biol Blood Marrow Transplant; 2009 Apr; 15(4):490-5. PubMed ID: 19285637
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus types 6 and 7 infection in pediatric hematopoietic stem cell transplant recipients.
Fule Robles JD; Cheuk DK; Ha SY; Chiang AK; Chan GC
Ann Transplant; 2014 Jun; 19():269-76. PubMed ID: 24881673
[TBL] [Abstract][Full Text] [Related]
8. Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults.
Sive JI; Thomson KJ; Morris EC; Ward KN; Peggs KS
Clin Infect Dis; 2012 Nov; 55(10):1362-70. PubMed ID: 22903766
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
Caruso Brown AE; Cohen MN; Tong S; Braverman RS; Rooney JF; Giller R; Levin MJ
Antimicrob Agents Chemother; 2015 Jul; 59(7):3718-25. PubMed ID: 25733509
[TBL] [Abstract][Full Text] [Related]
10. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients.
Unal E; Yen C; Saiman L; George D; Della-Latta P; van de Ven C; Morris E; Bradley MB; Del Toro G; Garvin J; Bhatia M; Schwartz J; Satwani P; Roman E; Cooney E; Wolownik K; Hawks R; Foley S; Cairo MS
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1188-97. PubMed ID: 17085312
[TBL] [Abstract][Full Text] [Related]
11. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of adenoviremia in pediatric patients undergoing hematopoietic stem cell transplantation: Is it alone sufficient to predict adenoviral disease?
Kanık Yüksek S; Arman Bilir Ö; Erat T; Gülhan B; Kanbur ŞM; Bayhan Gİ; Ok Bozkaya İ; Özkaya Parlakay A; Özbek NY
Pediatr Transplant; 2024 Feb; 28(1):e14696. PubMed ID: 38317343
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.
Yusuf U; Hale GA; Carr J; Gu Z; Benaim E; Woodard P; Kasow KA; Horwitz EM; Leung W; Srivastava DK; Handgretinger R; Hayden RT
Transplantation; 2006 May; 81(10):1398-404. PubMed ID: 16732176
[TBL] [Abstract][Full Text] [Related]
14. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.
Symeonidis N; Jakubowski A; Pierre-Louis S; Jaffe D; Pamer E; Sepkowitz K; O'Reilly RJ; Papanicolaou GA
Transpl Infect Dis; 2007 Jun; 9(2):108-13. PubMed ID: 17461995
[TBL] [Abstract][Full Text] [Related]
15. Risks and outcomes of adenovirus disease in pediatric hematopoietic stem cell transplant recipients-Comparison of current antiviral treatment options.
Thomas SJ; Young RT; Steinbach WJ; Lugo DJ
Transpl Infect Dis; 2021 Apr; 23(2):e13505. PubMed ID: 33174293
[TBL] [Abstract][Full Text] [Related]
16. Perioperative management after high-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for pediatric solid tumors.
Uehara S; Oue T; Nakahata K; Nara K; Ueno T; Owari M; Usui N; Miyamura T; Hashii Y
Eur J Pediatr Surg; 2015 Feb; 25(1):118-22. PubMed ID: 25111275
[TBL] [Abstract][Full Text] [Related]
17. Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant.
Meena JP; Phillips RS; Kinsey S
J Pediatr Hematol Oncol; 2019 Oct; 41(7):e467-e472. PubMed ID: 30969265
[TBL] [Abstract][Full Text] [Related]
18. Molecular monitoring of adenovirus reactivation in faeces after haematopoietic stem-cell transplantation to predict systemic infection: a retrospective cohort study.
Hum RM; Deambrosis D; Lum SH; Davies E; Bonney D; Guiver M; Turner A; Wynn RF; Hiwarkar P
Lancet Haematol; 2018 Sep; 5(9):e422-e429. PubMed ID: 30172346
[TBL] [Abstract][Full Text] [Related]
19. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.
Muller WJ; Levin MJ; Shin YK; Robinson C; Quinones R; Malcolm J; Hild E; Gao D; Giller R
Clin Infect Dis; 2005 Dec; 41(12):1812-6. PubMed ID: 16288409
[TBL] [Abstract][Full Text] [Related]
20. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
